Jordan Winter

8PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 21, 2026
Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies.

|Jun 06, 2024
IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer.

Mehrdad Zarei, Omid Hajihassani, Jonathan J Hue

|Jun 28, 2023
Increased glucose availability sensitizes pancreatic cancer to chemotherapy.

Ali Vaziri-Gohar, Jonathan J Hue, Ata Abbas

|Dec 15, 2022
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial.

Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly

|Oct 03, 2022
IDO1 Is a Therapeutic Target for Pancreatic Cancer-Associated Depression.

Jonathan J Hue, Hallie J Graor, Mehrdad Zarei

|Jun 10, 2022
Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors.

Ali Vaziri-Gohar, Joel Cassel, Farheen S Mohammed

Pageof 2

Frequent Collaborators

4 joint publications

Jonathan J Hue

4 joint publications

Ali Vaziri-Gohar

4 joint publications

Mehrdad Zarei

3 joint publications

Erryk S Katayama